Takeda Files Japan Application For Azilva/Amlodipine Combination, Plans Launch In 2014
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals has filed an application in Japan for a combination tablet including ARB Azilva (azilsartan) and calcium antagonist amlodipine for treatment of hypertension.